ChiCTR2500096760 版本V1.0 版本创建时间2025/02/06 09:47:49 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500096760 

最近更新日期:

Date of Last Refreshed on:

2025-02-06 09:47:43 

注册时间:

Date of Registration:

2025-02-06 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于健康行为改变整合理论的营养教育对乳腺癌化疗患者癌因性疲乏的影响研究

Public title:

A study of the effect of nutrition education based on the integrated health behavior change theory on cancer-related fatigue in breast cancer chemotherapy patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于健康行为改变整合理论的营养教育对乳腺癌化疗患者癌因性疲乏的影响研究

Scientific title:

A study of the effect of nutrition education based on the integrated health behavior change theory on cancer-related fatigue in breast cancer chemotherapy patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

顾丹凤 

研究负责人:

顾丹凤 

Applicant:

Danfeng Gu 

Study leader:

Danfeng Gu 

申请注册联系人电话:

Applicant telephone:

+86 15906182717

研究负责人电话:

Study leader's telephone:

+86 510 68088861

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1308594635@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1308594635@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

无锡市滨湖区和风路1000号

研究负责人通讯地址:

江苏省无锡市和风路1000号

Applicant address:

1000 Hefeng Road, Wuxi City, Jiangsu Province

Study leader's address:

1000 Hefeng Road, Wuxi City, Jiangsu Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

江南大学附属医院

Applicant's institution:

The Affiliated Hospital of Jiangnan University

研究负责人所在单位:

江南大学附属医院

Affiliation of the Leader:

The Affiliated Hospital of Jiangnan University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

LS2024542

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

江南大学附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Jiangnan University Affiliated Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-17 00:00:00

伦理委员会联系人:

任怡琳

Contact Name of the ethic committee:

Ren Yilin

伦理委员会联系地址:

江苏省无锡市和风路1000号

Contact Address of the ethic committee:

1000 Hefeng Road, Wuxi City, Jiangsu Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 510 68088861

伦理委员会联系人邮箱:

Contact email of the ethic committee:

elyn1227@qq.com

研究实施负责(组长)单位:

江南大学附属医院

Primary sponsor:

The Affiliated Hospital of Jiangnan University

研究实施负责(组长)单位地址:

江苏省无锡市和风路1000号

Primary sponsor's address:

1000 Hefeng Road, Wuxi City, Jiangsu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

Country:

China

Province:

Jiangsu

City:

单位(医院):

江南大学附属医院

具体地址:

江苏省无锡市和风路1000号

Institution
hospital:

The Affiliated Hospital of Jiangnan University

Address:

1000 Hefeng Road, Wuxi City, Jiangsu Province

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-financing

Target disease:

Cancer-related fatigue in breast cancer

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究以健康行为改变整合理论为指导,构建提高乳腺癌化疗患者膳食质量的营养教育方案,并通过随机对照实验评估该方案对癌因性疲乏的作用效果,为乳腺癌化疗患者的饮食指导提供依据,为癌因性疲乏的防治策略提供新的可能。  

Objectives of Study:

Based on the integrated theory of health behavior change, we constructed a dietary education programme to improve the dietary quality of patients undergoing chemotherapy for breast cancer, and to assess the effect of the programme on the symptoms of cancer-related fatigue through a randomized controlled trial, so as to provide a basis for dietary guidance for patients undergoing chemotherapy for breast cancer, and to provide a new possibility for the prevention and treatment strategy of cancer-related fatigue.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.经病理学确诊为乳腺癌,尚未发生转移及扩散现象的女性患者;
2.年龄≥18岁;
3.根据国际分类标准第十版(ICD-10)诊断为癌因性疲乏的患者;
4.术后处于化疗阶段,且距化疗疗程结束大于3个月的患者;
5.认知功能正常,有阅读能力;
6.自愿参与实验研究,并填写知情同意书;

Inclusion criteria

1.Female breast cancer without metastasis and diffusion; 2.Age >= 18 years old; 3.Patients with a diagnosis of cancer-related fatigue according to the International Classification of Diseases 10th Revision (ICD-10); 4.Patients in the postoperative chemotherapy phase who are >3 months from the end of their chemotherapy course; 5.Normal cognitive function and reading ability; 6.Voluntary participation in experimental research and sign the informed consent;

排除标准:

1.合并其他恶性肿瘤;
2.确诊乳腺癌前后诊断为精神疾病的患者;
3.严重合并症,如心脏病等;
4.处于妊娠或哺乳期;
5.参与其他干预性研究的患者;
6.研究人员认为其他原因不适合参与研究的患者;

Exclusion criteria:

1.Patients with a combination of other malignant tumours;
2.Diagnosed with mental illness before or after breast cancer diagnosis;
3.Suffering from serious comorbidities such as heart disease;
4.Pregnancy or lactation;
5.Patients participating in other interventional studies;
6.Other reasons that the researchers considered were not suitable for the study;

研究实施时间:

Study execute time:

From 2024-06-01 00:00:00 To 2025-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-02-14 00:00:00 To 2025-06-01 00:00:00  

干预措施:

Interventions:

组别:

干预组

样本量:

32

Group:

Intervention Group

Sample size:

干预措施:

常规护理+基于健康行为改变整合理论提高饮食质量的营养教育

干预措施代码:

Intervention:

Routine nursing + high dietary quality nutrition education based on the integrated health behavior change theory

Intervention code:

组别:

对照组

样本量:

32

Group:

Control group

Sample size:

干预措施:

常规护理

干预措施代码:

Intervention:

Routine nursing

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China 

Province:

Jiangsu 

City:

 

单位(医院):

江南大学附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Jiangnan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

癌因性疲乏

指标类型:

主要指标

Outcome:

Cancer-related fatigue

Type:

Primary indicator

测量时间点:

基线及干预12周后

测量方法:

Piper癌因性疲乏修正量表

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

Piper Fatigue Revised Scale

指标中文名:

膳食质量

指标类型:

主要指标

Outcome:

Dietary quality

Type:

Primary indicator

测量时间点:

基线及干预12周后

测量方法:

3天24小时膳食回顾法;中国健康饮食指数

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

3-day, 24-hour dietary recall data; Chinese Healthy Eating Index

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

基线及干预12周后

测量方法:

乳腺癌患者生命质量测定量表

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

Functional Assessment Of Cancer Therapy-Breast Cancer

指标中文名:

焦虑抑郁情绪

指标类型:

次要指标

Outcome:

Anxiety and depression

Type:

Secondary indicator

测量时间点:

基线及干预12周后

测量方法:

医院焦虑抑郁量表

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

Hospital Anxiety and Depression Scale

指标中文名:

自我效能

指标类型:

次要指标

Outcome:

Self-efficacy

Type:

Secondary indicator

测量时间点:

基线及干预12周后

测量方法:

癌症患者自我管理效能量表

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

Strategies Used by People to Promote Health

指标中文名:

营养状况

指标类型:

次要指标

Outcome:

Nutritional status

Type:

Secondary indicator

测量时间点:

基线及干预12周后

测量方法:

营养风险筛查工具,BMI、白蛋白、球蛋白等实验室检查指标。

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

Nutrition Risk Screening 2002, as well as BMI, albumin, globulin, and other laboratory mark

指标中文名:

营养知识

指标类型:

次要指标

Outcome:

Nutritional knowledge

Type:

Secondary indicator

测量时间点:

基线及干预12周后

测量方法:

基本营养知识问卷

Measure time point of outcome:

Baseline and 12 weeks after intervention

Measure method:

General Nutrition Knowledge Questionnaire

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

按照随机数字表将参与者1:1分为干预组和对照组。随机化采用电脑生成的随机数表进行,随机序列保存在密封的信封中,由独立于研究的第三方保管。

Randomization Procedure (please state who generates the random number sequence and by what method):

Participants were divided 1:1 into intervention and control groups according to a table of random numbers. Randomisation was carried out using a computer-generated table of random numbers and the random sequence was kept in sealed envelopes in the custody of a third party independent of the study.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲

Blinding:

Single blind

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1、病例记录表(纸质问卷);2、电子采集和管理系统(利用Excel表格对数据资料进行整理存档)。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Patient record form (paper questionnaire); 2. Electronic collection and management system (use of Excel sheets to organise and archive data information).

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-02-06 09:47:43